GefitinibAcquired drug resistance in EGFR-mutated bone metastasised lung adenocarcinoma: case report

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-019-71017-8
中图分类号
学科分类号
摘要
引用
收藏
页码:214 / 214
相关论文
共 50 条
  • [1] EGFR-Mutated Breast Metastasis of Lung Adenocarcinoma: A Case Report
    Dansin, Eric
    Carnot, Aurelien
    Servent, Veronique
    Daussay, Dorothee
    Robin, Yves-Marie
    Surmei-Pintilie, Ecaterina
    Lauridant, Geraldine
    Descarpentries, Clothilde
    Revillion, Francoise
    Delattre, Claire
    CASE REPORTS IN ONCOLOGY, 2015, 8 (01): : 164 - 168
  • [3] Drug resistance mechanisms and progress in the treatment of EGFR-mutated lung adenocarcinoma
    Sun, Ruizhu
    Hou, Zhansheng
    Zhang, Yankui
    Jiang, Bo
    ONCOLOGY LETTERS, 2022, 24 (05)
  • [6] Hepatic Rupture as the Initial Presentation of an EGFR-Mutated Lung Adenocarcinoma: A Case Report
    Mirallas, Oriol
    Bosch-Schips, Marc
    Pardo, Nuria
    Aubanell, Anton
    Salcedo-Allende, Maria Teresa
    Callejo, Ana
    Iranzo, Patricia
    Tabernero, Josep
    Felip, Enriqueta
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] EGFR-mutated lung adenocarcinoma with choroidal oligometastasis during treatment with gefitinib: a case report
    Hashimoto, Takafumi
    Osoegawa, Atsushi
    Abe, Miyuki
    Oki, Ryoko
    Karashima, Takashi
    Takumi, Yohei
    Kamada, Kosuke
    Miyawaki, Michiyo
    Sugio, Kenji
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (03) : 204 - 208
  • [8] Breast metastasis from EGFR-mutated lung adenocarcinoma: A case report and review of the literature
    Ota, Takayo
    Hasegawa, Yoshikazu
    Okimura, Akira
    Sakashita, Katsuya
    Sunami, Takeshi
    Yukimoto, Kiyotaka
    Sawada, Ryugo
    Sakamoto, Kazutsugu
    Fukuoka, Masahiro
    CLINICAL CASE REPORTS, 2018, 6 (08): : 1510 - 1516